Form 4: Director Carrie Cox Exercises Solventum RSU Awards

Director Carrie S. Cox acquired 4,916 shares of Solventum Corp common stock through the settlement of vested restricted stock units.

Summary

• Director Carrie S. Cox exercised 4,916 restricted stock units (RSUs) on April 30, 2026.
• The RSUs were converted into 4,916 shares of Solventum Corp (SOLV) common stock at a price of $0 per share.
• Following this transaction, the director's total beneficial ownership of common stock increased to 16,400 shares.
• The transaction represents the settlement of fully vested equity compensation.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents the standard settlement of vested equity compensation rather than a discretionary market purchase or sale.

Positives

• Director maintains a direct equity stake of 16,400 shares in the company, aligning interests with shareholders.

Negatives

• None identified in this filing.

Risks

• None identified in this filing.

Future Outlook

No forward-looking guidance provided in this filing.

Industry Context

StockSavvy.ai notes that this is a routine disclosure of equity compensation settlement for a corporate director, which is standard practice for publicly traded companies following the vesting of long-term incentive plans.

Comparison to Industry Standards

• The transaction follows standard corporate governance practices regarding the settlement of director equity compensation.
• The disclosure complies with SEC Section 16(a) reporting requirements for executive and director stock ownership changes.

Stakeholder Impact

• Minimal impact on shareholders as this is a routine equity settlement.

Next Steps

• No future actions or milestones mentioned.

Key Dates

Keywords

Solventum, SOLV, Form 4, Insider Trading, Director Equity, Restricted Stock Units